Page 15 - 2019年11月第30卷第21期
P. 15

江苏省某三级公立医院治疗高血压和糖尿病的原研药和仿制药

        利用分析           Δ


        唐媛媛    1,2* ,陈 敬 ,李 歆    1,4,5 # (1.南京医科大学医政学院,南京 211166;2.宿迁市第一人民医院采购供应部,
                         3
        江苏 宿迁 223899;3.北京大学药学院,北京 100191;4.南京医科大学药学院,南京 211166;5.南京医科大学

        全球健康中心,南京 211166)

        中图分类号 R956          文献标志码 A           文章编号 1001-0408(2019)21-2890-05
        DOI   10.6039/j.issn.1001-0408.2019.21.03

        摘   要   目的:为仿制药替代原研药的经济效益提供证据支持,提出促进仿制药使用的政策建议。方法:选取江苏省某三级公立
        医院治疗高血压和糖尿病的12种既有原研药又有仿制药的药物,逐季度分析2017-2018年原研药和仿制药使用量占比、使用金
        额占比、价格比和2018年仿制药替代原研药的潜在费用节省率。结果:2017年第1季度-2018年第4季度,原研药、仿制药使用数
        量占比分别由 24.53%上升至 39.12%、75.47%下降至 60.88%,使用金额占比分别由 39.45%上升至 61.47%、60.55%下降至
        38.53%,仿制药与原研药价格比从 0.50 下降到 0.40。在疗效一致的条件下,2018 年仿制药替代原研药潜在可节约费用 62.21 万
        元,费用节省率为47.65%。结论:仿制药替代原研药具有降低药品支出的作用,但该院仿制药使用或金额占比却逐渐下降。因
        此,有必要加快仿制药一致性评价的进程及临床等效研究,加大仿制药处方及合理使用的教育宣传,以提高医患对仿制药质量和
        疗效的认同,配合鼓励仿制药采购及使用的集中采购政策,促进仿制药利用以节约药品支出。
        关键词 高血压;糖尿病;仿制药;原研药;使用数量;使用金额;价格比;费用节省

        Utilization Analysis of the Original and Generic Drugs for Hypertension and Diabetes in a Tertiary Public
        Hospital in Jiangsu Province
                                     3
                        1,2
        TANG Yuanyuan ,CHEN Jing ,LI Xin      1,4,5 (1.School of Health Policy and Management,Nanjing Medical
        University,Nanjing 211166,China;2.Dept. of Procurement&Supply,Suqian First People’s Hospital,Jiangsu
        Suqian 223899, China;3.School of Pharmacy, Peking University, Beijing 100191, China;4.School of
        Pharmacy,Nanjing Medical University,Nanjing 211166,China;5.Center for Global Health,Nanjing Medical
        University,Nanjing 211166,China)

        ABSTRACT    OBJECTIVE:To provide evidence support for the economic benefits of generic drugs as substitutes for original
        drugs,and to provide suggestions for promoting the use of generic drugs. METHODS:Twelve kinds of drugs with both original
        and generic versions for treating hypertension and diabetes were selected from a tertiary public hospital in Jiangsu province. The
        proportion of usage quantity,the ratio of amount,price ratio were analyzed quarterly during 2017-2018. RESULTS:From the first
        quarter of 2017 to the fourth quarter of 2018,the ratio of quantity of original drugs increased from 24.53% to 39.12%,while that
        of generic drugs decreased from 75.47% to 60.88%;the ratio of amount of original drugs increased from 39.45% to 61.47%,
        while that of generic drugs decreased from 60.55% to 38.53%;the price ratio of generic drug to original drug decreased from 0.50
        to 0.40. With the same efficacy,the cost of generic drugs replacing original drugs in 2018 could save 622,100 yuan,and the cost
        savings rate could be 47.65%. CONCLUSIONS:Drug expenditure could be reduced by substituting original drug with generics,
        but the useage quantity and amount ratio of generic drug in this hospital is gradually declining. So,in order to save drug
        experditure,it is necessary to speed up the process of conformity evaluation and clinical equivalence study of generic drugs,
        increase the education and publicity of generic prescriptions and rational use,so as to improve doctors’and patients’recognition of
        the quality and efficacy of generic drugs,cooperate with the centralized procurement policy to encourage the purchase and use of
        generic drugs.
        KEYWORDS     Hypertension;Diabetes;Generic drug;Original drug;Usage quantity;Usage amount;Price ratio;Cost saving
            Δ 基金项目:国家自然科学基金资助项目(No.71874006,No.
        71673147)                                               药品支出在国家以及个人医疗费用总支出中一直
            *硕士研究生。研究方向:药事管理、卫生政策。电话:025-
                                                            占较大比例。2016年,江苏省药品费用为1 746亿元,占
        86868477。E-mail:718244219@qq.com
                                                            卫生总费用的 43.25% ;2014 年,上海市药品费用为
                                                                                [1]
            # 通信作者:教授,博士生导师,博士。研究方向:药事管理、药物
                                                                                            [2]
        政策。电话:025-86868477。E-mail:xinli@njmu.edu.cn         484.43 亿元,占卫生总费用的 37.93% 。为了控制药品
        ·2890  ·  China Pharmacy 2019 Vol. 30 No. 21                                中国药房    2019年第30卷第21期
   10   11   12   13   14   15   16   17   18   19   20